Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-1.50%||7.88||0.7%||$550.84m|
|GILD||Gilead Sciences, Inc.||0.63%||65.30||1.0%||$465.35m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.86%||481.16||2.7%||$431.65m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.55%||217.13||1.9%||$373.76m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.02%||155.29||2.0%||$316.00m|
|EXAS||EXACT Sciences Corp.||-0.67%||127.14||18.4%||$192.79m|
|NBIX||Neurocrine Biosciences, Inc.||2.24%||95.05||4.9%||$177.79m|
|CRSP||CRISPR Therapeutics AG||1.85%||123.11||0.6%||$176.91m|
|TWST||Twist Bioscience Corp.||0.87%||142.03||0.0%||$150.98m|
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.